Efficacy of Definitive Radiotherapy for Patients with Clinical Stage IIIB or IIIC Lung Adenocarcinoma and Epidermal Growth Factor Receptor (EGFR) Mutations Treated Using First- or Second-Generation EGFR Tyrosine Kinase Inhibitors

CONCLUSION: The addition of definitive RT to first- or second-generation EGFR TKI treatment does not significantly improve OS of patients with EGFR-mutated stage IIIB or IIIC lung adenocarcinoma. NCT03521154NCT05167851.PMID:38476120 | PMC:PMC10932622 | DOI:10.1155/2024/8889536

Source: Respiratory Care - March 13, 2024 Category: Respiratory Medicine Authors: Chih-Yen Tu Te-Chun Hsia Ying-Chun Lin Ji-An Liang Chia-Chin Li Chun-Ru Chien Source Type: research